Circulation 2009,120(16):1640–1645.PubMedCrossRef 6. Pothiwala P, Jain SK, Yaturu S: Metabolic syndrome and cancer. Metab Syndr Relat Disord 2009,7(4):279–288.PubMedCrossRef 7. Rosato V, Zucchetto A, Bosetti C, Dal Maso L, Montella M, Pelucchi C, Negri E, Franceschi S, La Vecchia C: Metabolic syndrome and endometrial LBH589 cell line cancer risk. Ann Oncol 2011,22(4):884–889.PubMedCrossRef 8. Pelucchi C, Negri E, Talamini R, Levi F, Giacosa A, Crispo A, Bidoli E, Montella M, Franceschi S, La Vecchia C: Metabolic syndrome is associated with colorectal cancer in men. Eur J Cancer 2010,46(10):1866–1872.PubMedCrossRef

9. Rosato V, Tavani A, Bosetti C, Pelucchi C, Talamini R, Polesel J, Serraino D, Negri E, La Vecchia C:

Metabolic syndrome and pancreatic cancer risk: a case-control study in Italy and meta-analysis. Metabolism 2011,60(10):1372–1378.PubMedCrossRef 10. Zhou JR, Blackburn GL, Walker WA: Symposium introduction: metabolic syndrome and the onset of cancer. Am J Clin Nutr 2007,86(3):s817-s819.PubMed 11. Laukkanen JA, Laaksonen DE, Niskanen L, Pukkala E, Hakkarainen A, Salonen JT: Metabolic syndrome and the risk of prostate cancer in Finnish men: a population-based study. Cancer Epidemiol Biomarkers Prev 2004,13(10):1646–1650.PubMed 12. Tande AJ, Platz EA, Folsom AR: The metabolic syndrome is associated with reduced risk of prostate cancer. Am J Epidemiol 2006,164(11):1094–1102.PubMedCrossRef 13. Russo A, Autelitano M,

Bisanti L: Metabolic syndrome and cancer risk. Eur J Cancer 2008,44(2):293–297.PubMedCrossRef Selleckchem Nutlin 3a 14. Martin RM, Vatten L, Gunnell D, Romundstad P, Nilsen TI: Components of the metabolic syndrome and risk of prostate cancer: the HUNT 2 cohort, Norway. Cancer Causes Control 2009,20(7):1181–1192.PubMedCrossRef 15. Inoue HAS1 M, Noda M, Kurahashi N, Iwasaki M, Sasazuki S, Iso H, Tsugane S: Impact of metabolic factors on subsequent cancer risk: results from a large-scale population-based cohort study in Japan. Eur J Cancer Prev 2009,18(3):240–247.PubMedCrossRef 16. Grundmark B, Garmo H, Loda M, Busch C, Holmberg L, Zethelius B: The metabolic syndrome and the risk of prostate cancer under competing risks of death from other causes. Cancer Epidemiol Biomarkers Prev 2010,19(8):2088–2096.PubMedCrossRef 17. Wallner LP, Morgenstern H, McGree ME, Jacobson DJ, St Sauver JL, Jacobsen SJ, Sarma AV: The effects of metabolic conditions on prostate cancer incidence over 15 years of follow-up: Results from the Olmsted County Study. BJU Int 2011,107(6):929–935.PubMedCrossRef 18. Osaki Y, Taniguchi S, Tahara A, Okamoto M, Kishimoto T: Metabolic syndrome and incidence of liver and breast cancers in Japan. Cancer Epidemiol 2012,36(2):141–147.PubMedCrossRef 19.